0000000000022565

AUTHOR

Ettore Guastella

showing 7 related works from this author

Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily.

2019

Objective To better characterize the metabolic alterations in various phenotypes of polycystic ovary syndrome (PCOS) in a large homogeneous (Sicilian) Mediterranean population with a low prevalence of obesity. Design Retrospective study. Patients A total of 1215 consecutively evaluated women with PCOS divided into four Rotterdam phenotypes (A, B, C and D) and in 108 matched ovulatory, nonhyperandrogenic women. Measurements BMI, fasting glucose, total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol and an oral glucose tolerance test. Results The overall prevalence of obesity was 31%, metabolic syndrome 6.6%, diabetes 2.1%, altered glucose metabolism 13.1%, and abnormal lipid pro…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismCarbohydrate metabolism03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicinemedicineHumanseducationSicilyTriglyceridesRetrospective Studieseducation.field_of_studybusiness.industryCholesterolCholesterol HDLCholesterol LDLGlucose Tolerance Testmedicine.diseasePolycystic ovaryPhenotypeObesityEndocrinologychemistry030220 oncology & carcinogenesisFemaleMetabolic syndromebusinessPolycystic Ovary SyndromeClinical endocrinologyREFERENCES
researchProduct

Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome

2010

Background: Although dyslipidemia is common in the polycystic ovary syndrome (PCOS), current diagnostic guidelines suggest to evaluate only plasma HDL-cholesterol and triglyceride concentrations, assuming that, in this disorder, cardiovascular risk is mainly due to the presence of the metabolic syndrome (MS). In the US, MS has been found in up to 50% of PCOS, but in other countries its prevalence is lower. Methods: We compared the prevalence of MS with that of increased LDL- and non-HDL-cholesterol levels in 350 Mediterranean PCOS women (244 anovulatory and 106 ovulatory), and 95 normo-weight and 90 body mass index (BMI)-matched controls. Results: The prevalence of MS was 7.1% in PCOS, high…

AdultMalemedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismYoung Adultchemistry.chemical_compoundEndocrinologyRisk FactorsInternal medicinemedicineHumansIncreased ldlTriglyceridesMetabolic SyndromeTriglyceridebusiness.industryCholesterol HDLnutritional and metabolic diseasesCholesterol LDLPrognosismedicine.diseaseLipidsPolycystic ovaryCholesterolEndocrinologychemistryCardiovascular DiseasesCase-Control StudiesFemalelipids (amino acids peptides and proteins)Metabolic syndromebusinessBody mass indexBiomarkersDyslipidemiaFollow-Up StudiesPolycystic Ovary SyndromeJournal of Endocrinological Investigation
researchProduct

When Periods Stop: Long-Term Consequences of PCOS

2009

Coronary artery calciummedicine.medical_specialtybusiness.industryInternal medicineEndometrial cancermedicineCardiologybusinessmedicine.diseasePolycystic ovaryTerm (time)
researchProduct

Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

2009

ObjectiveMuscle mass plays an important role in determining cardiovascular and metabolic risks in polycystic ovary syndrome (PCOS). In addition, whether lean mass influences carotid intima-media thickness (IMT) in PCOS has not been assessed.DesignProspective investigation.MethodsNinety-five women with PCOS were age- and weight-matched to 90 ovulatory controls. All women had dual X-ray absorptiometry for lean, fat and bone mass, and bone mass density (BMD). Serum testosterone, sex hormone-binding globulin, insulin, and glucose and carotid IMT were determined. Free androgen index (FAI) and insulin resistance (by QUICKI) were calculated.ResultsIn PCOS, waist circumference and insulin were high…

AdultMaleOvulationmedicine.medical_specialtySettore MED/09 - Medicina InternaBone densityAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiologySettore MED/13 - EndocrinologiaBody Mass IndexYoung AdultEndocrinologyWaist–hip ratioInsulin resistanceAbsorptiometry PhotonInternal medicinemedicineHumansInsulinTestosteroneMuscle SkeletalUltrasonographyPCOS Muscle mass Cardiovascular risk atherosclerosis endotheliumFree androgen indexWaist-Hip RatioInsulinBody Weightnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolarePolycystic ovaryEndocrinologyCarotid ArteriesLean body massAndrogensBody CompositionFemaleSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieBody mass indexPolycystic Ovary SyndromeEuropean journal of endocrinology
researchProduct

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

2009

Abstract OBJECTIVE: To evaluate the clinical and endocrine differences between main polycystic ovary syndrome (PCOS) phenotypes. DESIGN: To evaluate clinical and hormone parameters in a large group of consecutive women with PCOS diagnosed according Rotterdam criteria and divided according their phenotype. SETTING: University department of medicine. PATIENT(S): Three hundred eighty-two consecutive women with PCOS and 85 ovulatory controls. INTERVENTION(S): Evaluation of clinical and hormone parameters. MAIN OUTCOME MEASURE(S): Blood levels of gonadotropins, testosterone, sex-hormone-binding globulin, dehydroepiandrosterone sulfate, 17α-hydroxyprogesterone, progesterone, glucose, and insulin,…

AdultPCOS Lipids Insulin resistance Fertility Androgens Obesitymedicine.medical_specialtySettore MED/09 - Medicina Internaendocrine system diseasesEndocrine SystemSettore MED/13 - EndocrinologiaAnovulationYoung Adultchemistry.chemical_compoundDehydroepiandrosterone sulfateSex Hormone-Binding GlobulinInternal medicinePrevalencemedicineHumansTestosteroneRetrospective StudiesDehydroepiandrosterone SulfateFree androgen indexbusiness.industryHyperandrogenismObstetrics and GynecologyLuteinizing Hormonemedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryfemale genital diseases and pregnancy complicationsPhenotypeEndocrinologyReproductive MedicinechemistryCase-Control StudiesAndrogensFemaleFollicle Stimulating HormoneHyperandrogenismLuteinizing hormonebusinessPolycystic Ovary SyndromeHormoneFertility and Sterility
researchProduct

Uterine preservation in pelvic organ prolapse and urinary stress incontinence using robot-assisted laparoscopic surgery. Case report

2020

Highlights • Pelvic organ prolapse (POP) represents a common and bothersome condition in parous women. • The demand to “save” the uterus has fuelled a renewal of the surgical technique. • Robotic surgery was conceived with the intent to overcome the limitations of laparoscopic surgery. • The characteristics of the robotic system help surgeons to perform conservative management of POP.

Laparoscopic surgerySacrohysteropexyStress incontinencemedicine.medical_specialtygenetic structuresmedicine.medical_treatmentCase ReportUrinary incontinence03 medical and health sciences0302 clinical medicinemedicineRetropubic colposuspensionPelvic floorHysterectomyurogenital systembusiness.industryRobot-assisted laparoscopySacrohysteropexymedicine.diseasePelvic organ prolapseRoboticSurgerybody regionssurgical procedures operativemedicine.anatomical_structure030220 oncology & carcinogenesisRobot-Assisted Laparoscopic Surgery030211 gastroenterology & hepatologySurgerymedicine.symptombusinessAbdominal surgeryInternational Journal of Surgery Case Reports
researchProduct

La valutazione dell'iperespressione della proteina p16INK4a come possibile biomarcatore prognostico nelle lesioni cervicali intraepiteliali di basso …

2014

Settore MED/06 - Oncologia MedicaBiomarcatore prognostico proteina p16INK4a carcinoma cervicale intraepiteliale.
researchProduct